ℹ️
🇬🇧
Search
Search for publications relevant for "patient derived xenograft"
patient derived xenograft
Publication
Class
Person
Publication
Programmes
publication
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas
2022 |
Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport
publication
Introducing in vivo pancreatic cancer models for the study of new therapeutic regimens
2022 |
First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
publication
Quantitative In Vivo Monitoring of Hypoxia and Vascularization of Patient-Derived Murine Xenografts of Mantle Cell Lymphoma Using Photoacoustic and Ultrasound Imaging
2021 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma
2021 |
First Faculty of Medicine
publication
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
2015 |
Second Faculty of Medicine
publication
3,5,7-Substituted Pyrazolo[4,3-d]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders
2022 |
First Faculty of Medicine, Central Library of Charles University
publication
3,5,7-Substituted Pyrazolo[4,3-d]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models
2019 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL
2017 |
First Faculty of Medicine
publication
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma
2019 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma
2020 |
Second Faculty of Medicine, First Faculty of Medicine
publication
YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells are Regulated by LCK and Independent of LATS Activity
2018 |
Publication without faculty affiliation
publication
Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate
2019 |
Central Library of Charles University
publication
Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma
2018 |
Faculty of Medicine in Hradec Králové
publication
Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells
2020 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas
2022 |
First Faculty of Medicine
publication
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative
2017 |
First Faculty of Medicine
publication
Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML
2021 |
First Faculty of Medicine